Lendalizumab (Anti-Complement C5)
Product Specifications
CAS Number
2210314-30-8
Synonyms
ALXN1007, Olendalizumab
Target
Complement System
Applications
Immunology & Inflammation
Additionnal Information
Lendalizumab (Anti-Complement C5) is a proprietary antibody that targets the complement protein C5a with potential immunomodulating and anti-inflammatory activities. MW : 146.02 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
24893124 3x 1.0µg DNA
IL4 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Sign In for Pricing
View Details 
K1996403 1.0 µg DNA
RPLP2P4 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details MBS1399356-01 0.02 mg (E-Coli)
Recombinant Synechococcus sp. Spermidine synthase (speE)
Sign In for Pricing
View Details MBS1399356-02 0.02 mg (Yeast)
Recombinant Synechococcus sp. Spermidine synthase (speE)
Sign In for Pricing
View Details